NasdaqGS - Delayed Quote • USD
Nanobiotix S.A. (NBTX)
At close: April 24 at 4:00 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Dec 2020) | Next Qtr. (Mar 2021) | Current Year (2020) | Next Year (2021) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Dec 2020) | Next Qtr. (Mar 2021) | Current Year (2020) | Next Year (2021) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 1 | -- |
| Avg. Estimate | -- | -- | 2.56M | -- |
| Low Estimate | -- | -- | 1.76M | -- |
| High Estimate | -- | -- | 1.76M | -- |
| Year Ago Sales | -- | -- | -- | 2.56M |
| Sales Growth (year/est) | -- | -- | -- | -- |
Earnings History
| CURRENCY IN USD | ||||
|---|---|---|---|---|
| EPS Est. | -- | -- | -- | -- |
| EPS Actual | -- | -- | -- | -- |
| Difference | -- | -- | -- | -- |
| Surprise % | -- | -- | -- | -- |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Dec 2020) | Next Qtr. (Mar 2021) | Current Year (2020) | Next Year (2021) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | -0.58 | -0.43 | -2.46 | -2.52 |
| 30 Days Ago | -0.58 | -0.43 | -2.46 | -2.52 |
| 60 Days Ago | -0.58 | -0.43 | -2.46 | -2.52 |
| 90 Days Ago | -0.58 | -0.43 | -2.46 | -2.52 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Dec 2020) | Next Qtr. (Mar 2021) | Current Year (2020) | Next Year (2021) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | NBTX | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -- | -- | -- | 1.50% |
| Next Qtr. | -- | -- | -- | 11.40% |
| Current Year | -- | -- | -- | 5.20% |
| Next Year | -- | -- | -- | 13.40% |
| Next 5 Years (per annum) | -- | -- | -- | 11.09% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Initiated | Leerink Partners: Outperform | 12/8/2023 |
| Initiated | Evercore ISI Group: Outperform | 1/6/2021 |
Related Tickers
VALN Valneva SE
7.75
-3.12%
LENZ LENZ Therapeutics, Inc.
15.86
-0.38%
BOLD Boundless Bio, Inc.
11.03
+3.47%
PEPG PepGen Inc.
11.83
+0.94%
MGTX MeiraGTx Holdings plc
4.8600
-1.42%
HOWL Werewolf Therapeutics, Inc.
6.39
-0.78%
ANRO Alto Neuroscience, Inc.
14.20
+2.31%
IVA Inventiva S.A.
3.2400
-2.70%
TBPH Theravance Biopharma, Inc.
9.17
-0.54%
HLVX HilleVax, Inc.
12.58
-1.80%